Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Pharmacokinetics and tissue distribution of 3,4-diaminopyridine in rats.

Ishida N, Kondo Y, Chikano Y, Kobayashi-Nakade E, Suga Y, Ishizaki J, Komai K, Matsushita R.

Biopharm Drug Dispos. 2019 Sep;40(8):294-301. doi: 10.1002/bdd.2203.

PMID:
31419315
2.

A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy.

Ishizaki J, Nakano C, Kitagawa K, Suga Y, Sai Y.

Ann Pharmacother. 2020 Jan;54(1):29-35. doi: 10.1177/1060028019870445. Epub 2019 Aug 15.

PMID:
31416331
3.

Risk factors for oxaliplatin-induced vascular pain in patients with colorectal cancer and comparison of the efficacy of preventive methods.

Suga Y, Ikeda N, Maeda M, Staub AY, Shimada T, Yonezawa M, Kitade H, Katsura H, Okada M, Ishizaki J, Sai Y, Matsushita R.

J Pharm Health Care Sci. 2018 Aug 7;4:18. doi: 10.1186/s40780-018-0117-z. eCollection 2018.

4.

Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.

Kamiunten A, Shide K, Kameda T, Ito M, Sekine M, Kubuki Y, Hidaka T, Akizuki K, Tahira Y, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Shimoda H, Yamashita K, Matsuoka H, Shimoda K.

Int J Hematol. 2018 Oct;108(4):411-415. doi: 10.1007/s12185-018-2495-2. Epub 2018 Jul 9.

PMID:
29987745
5.

Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan.

Matsumoto R, Abe T, Ishizaki J, Kikuchi H, Harabayashi T, Minami K, Sazawa A, Mochizuki T, Akino T, Murakumo M, Osawa T, Maruyama S, Murai S, Shinohara N.

Jpn J Clin Oncol. 2018 Aug 1;48(8):771-776. doi: 10.1093/jjco/hyy094.

6.

The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis.

Okada M, Suemori K, Takagi D, Teraoka M, Yamada H, Ishizaki J, Matsumoto T, Hasegawa H, Hato N.

Auris Nasus Larynx. 2019 Feb;46(1):38-42. doi: 10.1016/j.anl.2018.05.011. Epub 2018 Jun 7.

PMID:
29885746
7.

Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.

Kamiunten A, Shide K, Kameda T, Sekine M, Kubuki Y, Ito M, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Akizuki K, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Matsuoka H, Shimoda K.

Int J Hematol. 2018 Jun;107(6):681-688. doi: 10.1007/s12185-018-2428-0. Epub 2018 Feb 27.

PMID:
29488167
8.

Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.

Ishizaki J, Takemori A, Suemori K, Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y, Harigai M, Arimura Y, Makino H, Yasukawa M, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan.

Arthritis Res Ther. 2017 Sep 29;19(1):218. doi: 10.1186/s13075-017-1429-3.

9.

Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.

Sekine M, Kubuki Y, Kameda T, Takeuchi M, Toyama T, Kawano N, Maeda K, Sato S, Ishizaki J, Kawano H, Kamiunten A, Akizuki K, Tahira Y, Shimoda H, Shide K, Hidaka T, Kitanaka A, Yamashita K, Matsuoka H, Shimoda K.

Eur J Haematol. 2017 May;98(5):501-507. doi: 10.1111/ejh.12863. Epub 2017 Mar 10.

PMID:
28152225
10.

Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study.

Itai S, Suga Y, Hara Y, Izumi K, Maeda Y, Kitagawa Y, Ishizaki J, Shimada T, Mizokami A, Sai Y.

J Pharm Health Care Sci. 2017 Jan 11;3:3. doi: 10.1186/s40780-016-0072-5. eCollection 2017.

11.

Improvement of Clinical Skills through Pharmaceutical Education and Clinical Research.

Ishizaki J.

Yakugaku Zasshi. 2017;137(1):9-12. doi: 10.1248/yakushi.16-00220-2. Review. Japanese.

12.

Non-occlusive mesenteric ischemia accompanied by aortic regurgitation after transcatheter aortic valve implantation.

Meguro K, Ishizaki J, Yanagisawa T, Koitabashi T, Kitamura T, Ako J.

Cardiovasc Interv Ther. 2017 Oct;32(4):425-429. doi: 10.1007/s12928-016-0450-9. Epub 2016 Dec 27.

PMID:
28028747
13.

Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan.

Abe T, Ishizaki J, Kikuchi H, Minami K, Matsumoto R, Harabayashi T, Sazawa A, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.

Urol Oncol. 2017 Feb;35(2):38.e1-38.e8. doi: 10.1016/j.urolonc.2016.08.016. Epub 2016 Sep 29.

14.

Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction - A comparative study.

Adnan E, Matsumoto T, Ishizaki J, Onishi S, Suemori K, Yasukawa M, Hasegawa H.

Clin Immunol. 2016 Dec;173:96-108. doi: 10.1016/j.clim.2016.09.007. Epub 2016 Sep 19.

PMID:
27658741
15.

High-throughput production of a stable isotope-labeled peptide library for targeted proteomics using a wheat germ cell-free synthesis system.

Takemori N, Takemori A, Tanaka Y, Ishizaki J, Hasegawa H, Shiraishi A, Ohashi Y.

Mol Biosyst. 2016 Jul 19;12(8):2389-93. doi: 10.1039/c6mb00209a.

PMID:
27203355
16.

[Pulmonary Nocardiosis due to Nocardia asiatica in a Patient with ANCA-associated Vasculitis].

Suemori K, Miyamoto H, Murakami S, Yamazaki H, Ishizaki J, Matsumoto T, Murakami Y, Hasegawa H, Yasukawa M.

Kansenshogaku Zasshi. 2015 Jul;89(4):470-5. Japanese.

PMID:
26554223
17.

Novel Autoantigens Associated with Lupus Nephritis.

Onishi S, Adnan E, Ishizaki J, Miyazaki T, Tanaka Y, Matsumoto T, Suemori K, Shudou M, Okura T, Takeda H, Sawasaki T, Yasukawa M, Hasegawa H.

PLoS One. 2015 Jun 22;10(6):e0126564. doi: 10.1371/journal.pone.0126564. eCollection 2015.

18.

Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis.

Suemori K, Hasegawa H, Ishizaki J, Matsumoto T, Onishi S, Sada E, Sugita A, Yasukawa M.

Intern Med. 2015;54(11):1421-5. doi: 10.2169/internalmedicine.54.3542. Epub 2015 Jun 1.

19.

Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.

Ishizaki J, Saito K, Nawata M, Mizuno Y, Tokunaga M, Sawamukai N, Tamura M, Hirata S, Yamaoka K, Hasegawa H, Tanaka Y.

Rheumatology (Oxford). 2015 Mar;54(3):405-12. doi: 10.1093/rheumatology/keu343. Epub 2014 Sep 2.

PMID:
25183834
20.

Enzymatic protein digestion using a dissolvable polyacrylamide gel and its application to mass spectrometry-based proteomics.

Takemori N, Takemori A, Ishizaki J, Hasegawa H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 15;967:36-40. doi: 10.1016/j.jchromb.2014.07.006. Epub 2014 Jul 14.

PMID:
25063926
21.

Protein kinase C inhibitor generates stable human tolerogenic dendritic cells.

Matsumoto T, Hasegawa H, Onishi S, Ishizaki J, Suemori K, Yasukawa M.

J Immunol. 2013 Sep 1;191(5):2247-57. doi: 10.4049/jimmunol.1203053. Epub 2013 Jul 22.

22.

Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan.

Takada N, Abe T, Shinohara N, Sazawa A, Maruyama S, Shinno Y, Sato S, Mitsuhashi K, Sato T, Sugishita K, Kamota S, Yamashita T, Ishizaki J, Hioka T, Mouri G, Ono T, Miyajima N, Sakuta T, Mochizuki T, Aoyagi T, Katano H, Akino T, Hirakawa K, Minami K, Kumagai A, Seki T, Togashi M, Nonomura K.

BJU Int. 2012 Dec;110(11 Pt B):E756-64. doi: 10.1111/j.1464-410X.2012.11609.x. Epub 2012 Oct 29.

23.

Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan.

Matsunaga T, Yamashita K, Kubuki Y, Toyama T, Imataki O, Maeda K, Kawano N, Satou S, Kawano H, Ishizaki J, Yoshida S, Kameda T, Sasaki T, Sekine M, Kamiunten A, Taniguchi Y, Hidaka T, Katayose K, K-Shimoda H, Shide K, Yamamoto S, Moritake H, Nunoi H, Makino S, Kitanaka A, Matsuoka H, Shimoda K.

Int J Hematol. 2012 Sep;96(3):342-9. doi: 10.1007/s12185-012-1146-2. Epub 2012 Jul 24.

PMID:
22825970
24.

Change in pharmacokinetics of mycophenolic acid as a function of age in rats and effect of coadministered amoxicillin/clavulanate.

Ishizaki J, Tsuda T, Suga Y, Ito S, Arai K, Sai Y, Miyamoto K.

Biol Pharm Bull. 2012;35(7):1009-13.

25.

Impaired shifting of visuospatial attention in Alzheimer's disease as shown by the covert orienting paradigm: implications for visual construction disability.

Ishizaki J, Meguro K, Nara N, Kasai M, Yamadori A.

Behav Neurol. 2013;26(1-2):121-9. doi: 10.3233/BEN-2012-110208.

26.

Reductive activation of 5-fluorodeoxyuridine prodrug possessing azide methyl group by hypoxic X-irradiation.

Tanabe K, Ishizaki J, Ando Y, Ito T, Nishimoto S.

Bioorg Med Chem Lett. 2012 Feb 15;22(4):1682-5. doi: 10.1016/j.bmcl.2011.12.106. Epub 2011 Dec 30.

PMID:
22248856
27.

[Investigation for relation of gustatory and olfactory impairment in patients receiving cancer chemotherapy].

Suga Y, Kitade H, Kawagishi A, Takeda K, Haruki K, Ishizaki J, Sai Y, Kasahara K, Arai K, Miyamoto K.

Gan To Kagaku Ryoho. 2011 Dec;38(13):2617-21. Japanese.

PMID:
22189228
28.

Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.

Kojima K, Shimada T, Nagareda Y, Watanabe M, Ishizaki J, Sai Y, Miyamoto K, Aburada M.

Biol Pharm Bull. 2011;34(10):1613-8.

29.

Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture.

Kawano N, Ochiai H, Yoshida S, Yamashita K, Shide K, Shimoda H, Hidaka T, Kubuki Y, Katayose K, Toyama T, Kawano H, Matsuoka H, Ishizaki J, Maeda K, Satou S, Yano T, Yamaguchi K, Takenaka K, Shimao Y, Oshima K, Ueda A, Shimoda K.

Int J Clin Oncol. 2012 Aug;17(4):336-40. doi: 10.1007/s10147-011-0292-5. Epub 2011 Sep 10.

PMID:
21904968
30.

Dysthymia and apathy: diagnosis and treatment.

Ishizaki J, Mimura M.

Depress Res Treat. 2011;2011:893905. doi: 10.1155/2011/893905. Epub 2011 Jun 27.

31.

Evaluation of selective competitive binding of basic drugs to alpha1-acid glycoprotein variants.

Ishizaki J, Fukaishi A, Fukuwa C, Yamazaki S, Tabata M, Ishida T, Suga Y, Arai K, Yokogawa K, Miyamoto K.

Biol Pharm Bull. 2010;33(1):95-9.

32.

Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy.

Ohno S, Kyo S, Myojo S, Dohi S, Ishizaki J, Miyamoto K, Morita S, Sakamoto J, Enomoto T, Kimura T, Oka Y, Tsuboi A, Sugiyama H, Inoue M.

Anticancer Res. 2009 Nov;29(11):4779-84.

33.

Collage technique may provide new perspectives for Alzheimer patients by exploring messages from their inner world.

Meguro M, Ishizaki J, Meguro K.

Dement Neuropsychol. 2009 Oct-Dec;3(4):299-302. doi: 10.1590/S1980-57642009DN30400006.

34.

Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model.

Matsuo Y, Ishihara T, Ishizaki J, Miyamoto K, Higaki M, Yamashita N.

Cell Immunol. 2009;260(1):33-8. doi: 10.1016/j.cellimm.2009.07.004. Epub 2009 Aug 4.

PMID:
19716124
35.

Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model.

Tai N, Kuwabara K, Kobayashi M, Yamada K, Ono T, Seno K, Gahara Y, Ishizaki J, Hori Y.

Inflamm Res. 2010 Jan;59(1):53-62. doi: 10.1007/s00011-009-0069-8. Epub 2009 Aug 5.

PMID:
19655230
36.

Gly80Ser polymorphism of phospholipase A2-IID is associated with cytokine inducibility in A549 cells.

Igarashi A, Shibata Y, Yamauchi K, Osaka D, Takabatake N, Abe S, Inoue S, Kimura T, Yamaguchi Y, Ishizaki J, Hanasaki K, Kubota I.

Respiration. 2009;78(3):312-21. doi: 10.1159/000213243. Epub 2009 Apr 10.

PMID:
19365107
37.

Normative data on Benton Visual Form Discrimination Test for older adults and impaired scores in Clinical Dementia Rating 0.5 participants: community-based study. The Osaki-Tajiri Project.

Kasai M, Ishizaki J, Ishii H, Yamaguchi S, Yamadori A, Meguro K.

Psychiatry Clin Neurosci. 2009 Feb;63(1):9-16. doi: 10.1111/j.1440-1819.2008.01901.x.

38.

[Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation].

Suga Y, Kumazaki M, Nishigami J, Takeda K, Kawagishi A, Ishizaki J, Inokuchi M, Miyamoto K, Arai K.

Gan To Kagaku Ryoho. 2009 Jan;36(1):93-6. Japanese.

PMID:
19151570
39.

The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction.

Ishida S, Yamane S, Nakano S, Yanagimoto T, Hanamoto Y, Maeda-Tanimura M, Toyosaki-Maeda T, Ishizaki J, Matsuo Y, Fukui N, Itoh T, Ochi T, Suzuki R.

Immunology. 2009 Sep;128(1 Suppl):e315-24. doi: 10.1111/j.1365-2567.2008.02965.x. Epub 2008 Nov 19.

40.

Selective drug delivery to bone using acidic oligopeptides.

Ishizaki J, Waki Y, Takahashi-Nishioka T, Yokogawa K, Miyamoto K.

J Bone Miner Metab. 2009;27(1):1-8. doi: 10.1007/s00774-008-0004-z. Epub 2008 Nov 19. Review. No abstract available.

PMID:
19018455
41.

Discovery of novel non-peptide thrombopoietin mimetic compounds that induce megakaryocytopoiesis.

Yamane N, Takahashi K, Tanaka Y, Kato K, Takayama M, Ohyabu N, Shiota T, Takenaka H, Yoshida Y, Hara S, Murashi T, Nakamura E, Nishitani Y, Ishizaki J, Yamane S, Nagata K, Koizumi K, Yutsudo T, Suzuki R, Itoh T, Takemoto H.

Biosci Rep. 2008 Oct;28(5):275-85. doi: 10.1042/BSR20080086.

PMID:
18620546
42.

Transcriptomic analysis of nephrotoxicity induced by cephaloridine, a representative cephalosporin antibiotic.

Rokushima M, Fujisawa K, Furukawa N, Itoh F, Yanagimoto T, Fukushima R, Araki A, Okada M, Torii M, Kato I, Ishizaki J, Omi K.

Chem Res Toxicol. 2008 Jun;21(6):1186-96. doi: 10.1021/tx800008e. Epub 2008 May 23.

PMID:
18500788
43.
44.

Identification of new amine acceptor protein substrate candidates of transglutaminase in rat liver extract: use of 5-(biotinamido) pentylamine as a probe.

Ichikawa A, Ishizaki J, Morita M, Tanaka K, Ikura K.

Biosci Biotechnol Biochem. 2008 Apr;72(4):1056-62. Epub 2008 Apr 7.

45.

Characterization of novel non-peptide thrombopoietin mimetics, their species specificity and the activation mechanism of the thrombopoietin receptor.

Yamane N, Tanaka Y, Ohyabu N, Yamane S, Maekawa K, Ishizaki J, Suzuki R, Itoh T, Takemoto H.

Eur J Pharmacol. 2008 May 31;586(1-3):44-51. doi: 10.1016/j.ejphar.2008.02.060. Epub 2008 Feb 29.

PMID:
18377892
46.

Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.

Ishizaki J, Ito S, Jin M, Shimada T, Ishigaki T, Harasawa Y, Yokogawa K, Takami A, Nakao S, Miyamoto K.

Biopharm Drug Dispos. 2008 May;29(4):195-203. doi: 10.1002/bdd.604.

PMID:
18240156
47.

Changes in regional cerebral blood flow following antidepressant treatment in late-life depression.

Ishizaki J, Yamamoto H, Takahashi T, Takeda M, Yano M, Mimura M.

Int J Geriatr Psychiatry. 2008 Aug;23(8):805-11. doi: 10.1002/gps.1980.

PMID:
18214999
48.

Alzheimer's patients do not show left unilateral spatial neglect but exhibit peripheral inattention and simplification.

Kasai M, Ishizaki J, Meguro K.

Dement Neuropsychol. 2007 Oct-Dec;1(4):374-380. doi: 10.1590/S1980-57642008DN10400008.

49.

Toxicogenomics of drug-induced hemolytic anemia by analyzing gene expression profiles in the spleen.

Rokushima M, Omi K, Imura K, Araki A, Furukawa N, Itoh F, Miyazaki M, Yamamoto J, Rokushima M, Okada M, Torii M, Kato I, Ishizaki J.

Toxicol Sci. 2007 Nov;100(1):290-302. Epub 2007 Aug 13.

PMID:
17698508
50.

Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.

Khemawoot P, Nishino K, Ishizaki J, Yokogawa K, Miyamoto K.

Eur J Pharmacol. 2007 Nov 21;574(1):71-6. Epub 2007 Jun 29.

PMID:
17651723

Supplemental Content

Loading ...
Support Center